VVOS

VVOS

USD

Vivos Therapeutics Inc. Common Stock

$2.630-0.010 (-0.379%)

Prix en Temps Réel

Healthcare
Dispositifs médicaux
États-Unis

Graphique des Prix

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$2.640

Haut

$2.660

Bas

$2.554

Volume

0.00M

Fondamentaux de l'Entreprise

Capitalisation Boursière

16.0M

Industrie

Dispositifs médicaux

Pays

United States

Statistiques de Trading

Volume Moyen

0.12M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.91Actuel $2.630Haut $6.28

Actualités Connexes

GlobeNewswire

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to close later this

Voir plus
Vivos Therapeutics Signs Definitive Agreement to  Acquire Largest Sleep Center Operator in Nevada
Analyst Upgrades

Ascendiant Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $6.2

Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics with a Buy and lowers the price target from $6.6 to $6.2.

Voir plus
Ascendiant Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $6.2
GlobeNewswire

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., March 31,

Voir plus
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
GlobeNewswire

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

LITTLETON, Colo., March 28, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and

Voir plus
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.